X-linked intellectual disability (XLID) is a heterogeneous disorder that can be classified as either non-syndromic, when cognitive impairment is the only feature, or as syndromic. In the latter, the cognitive impairment is associated with dysmorphic, metabolic and/or neurological features. Until now, over 140 XLID-associated genes have been identified 1
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, mainly through the implementation of comparative genome hybridization and next generation sequencing technologies 2; 3 . Many of these genes converge into a few common functional networks as ID proteins often participate in interconnected cellular and molecular processes, including neurogenesis, neuronal migration, synapse formation and function 4; 5 . Here we report that hypomorphic defects in the replicative DNA polymerase cause a human XLID syndrome. In 5 families, we identified mutations in POLA1 (Xp22.1-p21. 3 . MIM: 312040), which encodes the p180 catalytic subunit of the heterotetrameric DNA Polymerase -primase (POL ). All affected individuals present with different degrees of intellectual disability and moderate to severe short stature, microcephaly, hypogonadism and variable congenital malformations (Fig 1) . Written informed consent was obtained from all parents on behalf of the affected individuals, according to local ethical protocols and the principles of the Declaration of
Helsinki. An overview of the clinical features of the affected individuals is presented in Table   1 . More detailed clinical descriptions and pedigrees are provided in the Supplemental Note and Fig 1. The core clinical features consist of intellectual disability and developmental delay, ranging from mild to severe, pronounced proportionate short stature (ranging from -2 SD to -7.7 SD) and microcephaly (ranging from 3.1 SD to -7.8 SD) pointing towards a clear growth deficiency syndrome of prenatal origin. Hypogonadism is also frequently evident. The index case of Family B also developed seizures and secondary neurological and orthopedic manifestations, which were not seen in the other individuals. In two affected individuals a congenital heart malformation was present at birth (family C). Although we cannot define a recognizable facial gestalt, mild upslant of the palpebral fissures are present in 4 cases ( Fig   1A-G) .
Of the three mammalian replicative DNA polymerases (POL , POL and POL ), POLprimase is the only polymerase that can initiate de novo DNA synthesis from licensed replication origins as well as mediating Okazaki fragment synthesis during lagging strand DNA replication [6] [7] [8] . POL is also involved in other cellular processes such as DNA damage response signaling from stalled replication forks, telomere maintenance, and epigenetic regulation [9] [10] [11] [12] [13] [14] . Interestingly, a recurrent deep intronic mutation in POLA1 was recently found as causing X-linked reticulate pigmentary disorder (XLPDR. MIM: 301220), a primary immunodeficiency with autoinflammatory features, as well as skin hyperpigmentation and prototypical facial gestalt 15; 16 . This intronic mutation creates a novel exon 13a into the POLA1 transcript, reducing the total amount of p180-POL protein. XLPDR individuals do not exhibit intellectual disability, altered body growth or smaller head circumference, which might indicate tissue-specific differences in abnormal splicing. Conversely, our cases do not show any of the XLPDR related symptoms, except proband E who suffered from recurrent infections.
POLA1 mutations were identified either using classical linkage analysis followed by Sanger sequencing of all 17 genes present in the 6 cM interval (LOD score 2.6) (Family A) 17 , by a custom-designed microcephaly/microcephalic dwarfism Sure Select capture panel consisting of 63 genes (Family C), by single WES (Family B) or by trio WES (Families D and E). In family A, a missense mutation, c.236T>G in exon 3 of POLA1 leading to a p.Ile79Ser change was identified, which segregates with the disease in all 4 affected individuals and obligate carrier mothers (Fig1H). The sequence variant results in substitution of an isoleucine, a nonpolar amino acid to a serine, a polar amino acid. This residue and its surrounding sequence is highly conserved and p.IIe79Ser was predicted to be deleterious by various in silico methods. (Fig S1, S2) . In family B, exome analysis identified a missense mutation c.4142C>T leading to p.Pro1381Leu mutation. This mutation affects a conserved residue and is also present in the unaffected mother, maternal grandmother and sister (Fig 1I, S1, S2) . In family C, a splice-site variant, c.507+1G>A located in the donor splice site of intron 6 of POLA1 was identified. The variant was identified in the affected proband and his affected maternal cousin (Fig 1J) . The c.507+1G>A splice-site variant was predicted to completely abolish the donor splice site using 5 different splicing prediction programs. RNA studies were performed showing that c.507+1G>A prevents normal splicing and leads to the production of two abnormally-spliced transcripts (Fig S1) . The larger c.507+1G>A transcript results from activation of a cryptic splice donor site within intron 6 leading to insertion of the first 60 nucleotides of intron 6. This is predicted to cause insertion of 15 amino acids and the introduction of a premature termination codon p.(Thr170_Ser1462delins15*) truncating the potential p180-POL product upstream of the domains responsible for DNA binding and catalytic activity. The smaller c.507+1G>A transcript results from exon 6 skipping, leading to an in-frame deletion which is predicted to produce a protein product lacking 21 amino acids, i.e. p.(Lys149_Glu169del) (Fig S1) . In Family D, a hemizygous deletion of exon 6 was identified via exome sequencing, leading to an in-frame deletion producing a protein lacking 21 amino acids as seen for the smaller transcript in Family C. This deletion arose de novo in the index case (Fig S1) . Exome sequencing in Family E identified a de novo variant c.328G>A affecting the last nucleotide of exon 4 leading to p.Gly110Arg. Bioinformatic analysis predicts a high probability of intron 4 missplicing upon c.328G>A replacement and subsequent qRT-PCR analysis displayed a dramatic reduction of POLA1 mRNA compared to cells derived from unaffected males, even more profound than that observed in XLPDRderived fibroblasts (Starokadomskyy et al., 2016) (Fig S1) . None of the above identified variants are present in the dbSNP, 1000 Genomes, ExAC or gnomAD databases, and were submitted to ClinVar, accession number XXXXX. All missense mutations affect conserved amino acids and are predicted to be deleterious by various in silico methods (Fig S2) . In addition, in the 3 familial cases (Families A-C), all obligate female carriers show significant to complete skewing of X inactivation (Fig 1H-J) . DNA polymerases are highly expressed during development, when rapid DNA replication and cell division is required 18; 19 . To further investigate POL /POLA1 in mammalian brain development, we assessed Pola1 expression by in situ hybridisation in the embryonic and adult mouse brain. In the mouse forebrain, Pola1 is expressed in those zones containing proliferating cells in the developing embryonic neocortex (Fig 2A) as well as in the lateral and medial ganglionic eminences (not shown). After birth, the gene is transcribed in cells that remain proliferating in the ventricular and subventricular zone of the striatum (Fig 2B) . These data suggest that Pola1 has a role in neurogenesis throughout life. Additionally, pola1 expression by in situ hybridization in developing zebrafish embryos shows early and intense staining in the developing brain 20; 21 , whilst Pol activity appears highest in isolated neurons from developing rat brain cerebral cortex when the mitotic activity is at its peak 22 .
Conversely, an insertional mutation in pola1 of zebrafish (pola1 hi1146Tg ) presented with central nervous system necrosis, small head and eyes, an inflated hindbrain ventricle, a thin and often curved body and a rounder yolk with no extension at day 2 23 . At days 3-5, the necrosis spread throughout the body resulting in overt body wasting, small head and eyes 23 .
We examined POL protein levels in proband-derived cell lines from families A, B, C and E (Fig 2C-F) . Cell lines from the Family D proband were unavailable. Using whole cell extracts (WCE) from lymphoblastoid cell lines (LCLs) derived from affected individuals from family A and B, we found POL protein levels comparable to that of wild-type (WT) LCLs (Fig 2C, D) .
In contrast, WCE derived from family C LCLs or dermal primary fibroblasts from family E proband, both showed marked reduction in POL levels (Fig 2E, F) . These findings are consistent with the RT-PCR analysis from each of these two families ( Fig S1) . We next assessed POL enrichment on chromatin using LCLs derived from affected individuals.
Whilst chromatin extracts from family A and B tended towards slightly reduced POL levels compared to WT LCLs, the reduction did not reach statistical significance (Fig S3A, B) . In contrast, chromatin extracts from family C LCLs showed approx. 60% reduction in POL levels compared to WT LCLs ( Fig S3C) . Furthermore, chromatin recruitment of the additional POL -primase subunit proteins p68-POLA2 and p48-PRIM1 appeared unaffected in proband LCL extracts from families A, B and C, suggesting the stoichiometry of the POL -primase component subunits is largely preserved (Fig S3D) .
Reduced cellular proliferation represents a logical pathomechanism underlying growth retardation and microcephaly in human disorders such as the prototypical microcephalic primordial dwarfism of Seckel syndrome (MIM: 210600), or Meier-Gorlin syndrome (MIM: 224690), which is caused by mutations in multiple components of the DNA replication licensing machinery [24] [25] [26] . C.elegans div-1 (division delayed) allele encoding the B subunit of DNA polymerase -primase delays cell division and lethally disrupts cell polarity in embryos 27 whilst POL1 mutants of S. cerevisiae and a PolA1 mutant (p.Ser1180Phe) of the mouse mammary carcinoma line FM3A are each associated with temperature-sensitive growth delay 11; 28 . Nonetheless, we did not observe a marked delay in proliferation of proband LCLs from families A, B and C compared to WT (Fig S4) . Therefore, we carefully assessed different aspects of DNA replication capacity in family C LCLs specifically, as these showed a pronounced reduction in POL -primase expression and chromatin localisation (Fig 2E, Fig   S3C) . POL is characterised by limited processivity and it exonucleolytic proofreading capacity. Therefore, in contrast to POL and POL , POL is unsuited to efficiently and accurately duplicate long DNA templates 29; 30 . Using DNA fibre combing analysis of ongoing unperturbed DNA replication in LCLs obtained from the proband of family C and his unaffected father, we observed similar rates of replication fork progression ( Fig   3A) . This was perhaps not entirely unanticipated since POLbulk of the genomic DNA and POLA1 encodes a core product of a fundamentally essential cellular process, hence any viable defects in this gene would have to be hypomorphic. POL is essential for viability 23; 27; 31 ; indeed POLA1 has a negative residual variation intolerance/genic intolerance score of -0.795, indicating it is under substantial purifying selection 15; 32 . This is further illustrated by the absence of microdeletions involving POLA1 in males, both in control and diseases CNV databases, as well as the identification of a female X-autosome translocation disrupting POLA1. In this female, in contrast to what normally happens, the wild-type X chromosome remained active in all her cells, probably as a result of selection against cells that contained the non-functional POLA1
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. DNA fibre combing analysis did reveal a reduction in new initiation events in family C proband LCLs of 5.9% (n= 170 fibres) compared to 9.6% (n= 178 fibres) observed in paternal LCLs, indicative of initiation 34; 35 . Consistent with this, we also observed increased inter-origin distance (IOD) in family C proband LCLs compared to those of the father (Fig 3B) . This would also be consistent with possible impairments in dormant origin firing 34; 35 .Furthermore, we found an increase in asymmetric forks and an accumulation of longer replication tracts in family C proband LCLs compared to those of the father (Fig 3C,   D) . Collectively, analyses of multiple replication fork parameters in these POLA1 deficient LCLs demonstrated several phenotypes consistent with spontaneously diminished productive replication initiation under unperturbed exponential growth conditions. These replication phenotypes are reminiscent of those recently reported for Pol impairment 36 .
We next reasoned that additional impairments of DNA replication in POLA1 LCLs could be context dependent; DNA replication under conditions of replication stress may represent that physiological context 37 . Disrupting the temporally coordinated balance between stem cell proliferation and differentiation programmes profoundly impacts upon brain and body growth 38; 39 . Rapidly proliferating murine embryonic stem cells exhibit constitutive replication stress and are highly dependent on replication-coupled pathways to preserve genome integrity and execute DNA replication efficiently and effectively 40 . Therefore, we reasoned that DNA replication in POLA1-mutated cells may be hypersensitive to replication stress conditions, particularly if dormant origin capacity was restricted due to a genetic defect of this nature 34;
35
. When we examined DNA fibres under conditions of replication stress by limiting deoxyribonucleotide availability via treatment with the ribonucleotide reductase inhibitor hydroxyurea (HU), we observed an approximately 2-fold increase in stalled replication forks in combed fibres from paternal LCLs (Fig 4A) . We next assessed DNA replication via pulse labelled EdU incorporation within LCL populations in a kinetic fashion following HU treatment (Fig 4B-D) . Figure 4B shows representative EdU flow cytometry profiles from paternal and proband LCLs from family C, either untreated (Unt) or at significantly less EdU upon HU-treatment compared to control LCLs (Fig 4B,C) . This is a POLA1-dependent cellular phenotype as demonstrated by siRNA of POLA1 in U2OS cells (Fig S5) .
Similarly, proband LCLs from family A and family B exhibited significantly reduced EdU incorporation indicative of impaired DNA replication following treatment with HU ( Fig 4D) . 
D. Increasing amounts of WCE from LCLs derived from wild-type (WT) and a POLA1-mutant
individual from family B were assessed for POL expression levels. POL expression was comparable.
E. Increasing amounts of WCE from LCLs derived from wild-type (WT) and a POLA1-mutant
individual from family C were assessed for POL expression levels. Here, POL was markedly reduced compared to WT LCLs.
F. POL levels were assessed using WCE derived from dermal fibroblast from WT, XLPDRindividual and the POLA1-mutant individual of family E. POL was reduced in both instances of POLA1 mutation. 
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